Bringspring tech.(SZ:300290) Zhong Guo Zheng Quan Bao·2026-01-10 09:41Core Viewpoint - The expectation of Rongke Technology being "backdoor listed" has been directly negated following the announcement of Chaojuhuan's listing guidance report, leading to a significant drop in Rongke Technology's stock price by nearly 30% over three trading days [1][4]. Group 1: Stock Price Movement - Rongke Technology's stock price fell nearly 30% from January 7 to January 9, 2026, following the news of Chaojuhuan's listing guidance [1][4]. - The China Securities Regulatory Commission (CSRC) confirmed that Chaojuhuan published its initial public offering (IPO) guidance report on January 6, 2026, with CITIC Securities as the advisory institution [2]. Group 2: Company Clarifications - Rongke Technology issued a statement on January 9, 2026, clarifying that there are no undisclosed matters or plans related to Chaojuhuan, nor any arrangements for backdoor listing [1][4]. - The company has previously denied rumors regarding a potential acquisition of Chaojuhuan for a price between 12 billion and 22 billion yuan, stating that no asset evaluation or related preparations have been conducted [3]. Group 3: Financial Performance - Rongke Technology has been experiencing poor financial performance, with net losses reported for both 2024 and the first three quarters of 2025, amounting to a loss of 31.69 million yuan in the latter period [5]. - The company maintains that its core business operations are stable and not at risk of becoming a shell company, attributing short-term financial pressures to industry conditions and investments in product upgrades [5]. Group 4: Management Actions - Senior management at Rongke Technology has engaged in share reductions, with the Vice President Liu Bin selling 63,000 shares at an average price of 27.33 yuan per share between September 29 and October 10, 2025, and 84,000 shares at an average price of 8.71 yuan per share on April 26, 2024 [5]. - The company is facing legal issues, with part of its bank funds frozen due to a lawsuit filed by Zhanjiang CDC over a contractual dispute, resulting in a freeze of 1.153 million yuan [6].